[Active immunotherapy of L 1210 leukemia given after the graft of the tumor].
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000818:Animals; D015478:Antigens, Heterophile / Q000627:therapeutic use; D001500:BCG Vaccine / Q000627:therapeutic use*; D064987:Cell- and Tissue-Based Therapy; D005260:Female; D006801:Humans; D007939:Leukemia L1210 / Q000276:immunology / Q000401:mortality / Q000628:therapy*; D007945:Leukemia, Lymphoid / Q000628:therapy; D051379:Mice; D009368:Neoplasm Transplantation; D011830:Radiation Effects
D000276:Adjuvants, Immunologic; D015478:Antigens, Heterophile; D001500:BCG Vaccine
Immunothérapie active de la leucémie L 1210 appliquée après la greffe tumorale.